Press release
Online Immunofluorescence Guide for Diagnosis of Autoimmune Diseases
The Online Immunofluorescence Guide for the Modern Autoimmunity Laboratory from ORGENTEC Diagnostika and the GRÜNE CLUB AUTOIMMUN
Whether it is the immunofluorescence pattern of antinuclear antibodies (ANA) on HEp-2 cells or the detection of autoantibodies on tissue sections from rats: The online Immunofluorescence Guide for the diagnosis of autoimmune disorders features carefully selected and brilliant pictures of typical indirect immunofluorescence patterns of common autoantibodies. Compact notes provide useful indications how test results have to be interpreted.
Authoress of the online reference work is Barbara Fabian of the GRÜNE CLUB AUTOIMMUN, who accounts for the photographs to this cost-free digital book as well. The Online Immunofluorescence Guide for the Modern Autoimmunity Laboratory is available in English and in German.
Modern indirect immunofluorescence assays, called IFA for short, are based on the fundamental work of the American physician Albert Hewett Coons in the early 1940s. The immunology pioneer was the first who conceptualised and developed various immunofluorescence techniques for the detection of antibodies. Since that time immunofluorescence techniques have been continually improved and methodically refined. Nowadays, indirect immunofluorescence assays still allow for cost-effective and high-quality medical diagnosis, including autoimmune disease diagnostics.
Based in Mainz, ORGENTEC Diagnostika is a global leader in the development and marketing of test systems for autoimmune diagnostics and serological tests for infectious disease. ORGENTEC has developed numerous highly specific ELISA test systems, immunoblot and immunofluorescence tests, the Alegria® random access analyser, and the rheumachec® rapid test. – www.orgentec.com
The GRÜNE CLUB AUTOIMMUN is an informal association of scientists, laboratory directors, laboratory workers, students, and others interested in immunofluorescence. The club supports the exchange of information between colleagues and continuing education in the field of autoimmune diagnostics. – www.der-gruene-club.at
ORGENTEC Diagnostika GmbH
- Public Relations -
Tobias Stolzenberg
Dr. Friederike Hammar
Carl-Zeiss-Straße 49-51
55129 Mainz, Germany
www.orgentec.com
orgentec@orgentec.com
Tel. +49 (0) 6131 9258-677, -674
Fax +49 (0) 6131 9258-58
tobias.stolzenberg@orgentec.com
friederike.hammar@orgentec.com
ORGENTEC’s media channels:
www.autoimmunityblog.wordpress.com
www.youtube.com/ORGENTECMainz
www.twitter.com/ORGENTEC
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Online Immunofluorescence Guide for Diagnosis of Autoimmune Diseases here
News-ID: 220852 • Views: …
More Releases from ORGENTEC Diagnostika
Fully Automated Chlamydia Diagnostics from ORGENTEC
Mainz, June 19, 2012 – ORGENTEC Diagnostika (www.orgentec.com) has introduced six new tests for the diagnosis of infectious diseases. The new ELISA tests detect antibodies against Chlamydia trachomatis and Chlamydia pneumoniae. In addition, these test systems make it possible to differentiate between acute, latent, and chronic infection with these widespread bacterial pathogens.
The new tests for the serological diagnosis of Chlamydia were developed specifically for Alegria®, ORGENTEC Diagnostika’s random access analyser.…
Autoantibody Diagnostics in Autoimmune Liver Diseases
ORGENTEC Diagnostika (www.orgentec.com) has developed four new laboratory tests for the diagnosis of autoimmune liver diseases. These tests are now on the market. They are based on ELISA technology and were specifically developed for fully automated analysis with Alegria®.
The new tests systems, called Anti-Sp100, Anti-gp210, Anti-LKM-1, and Anti-SLA, reliably detect specific autoantibodies that are characteristic of various autoimmune liver diseases. The tests thus also allow for reliable differentiation between these…
A New Healthcare App: ORGENTEC Autoimmunity Guide
The ORGENTEC Autoimmunity Guide is now available for download from the Apple iTunes App Store and the Android Market. This app from Mainz-based ORGENTEC Diagnostika GmbH (www.orgentec.com) makes it possible to call up information about autoimmune diseases easily and comfortably from a smartphone or tablet – precisely, compactly, and without extensive searching.
The ORGENTEC app offers comprehensive information about the diagnosis and monitoring of autoimmune diseases by means of antibody detection.…
Autoimmune Disease Diagnostics: High Sensitivity ACPA Test for Rheumatoid Arthri …
Mainz, November 16, 2011 – For Medica 2011, ORGENTEC Diagnostika presents a new laboratory test for the diagnosis of rheumatism. The highly sensitive Anti-CCP hs (high sensitive)® test makes possible the early diagnosis of rheumatoid arthritis (RA), which in turn allows for successful treatment of this autoimmune disease.
The new Anti-CCP hs (high sensitive)® test is the most recent development in the area of ACPA testing. This innovate enzyme immunoassay combines…
More Releases for Immunofluorescence
Rising Chronic Disease Prevalence Driving Growth In Immunofluorescence Assay Mar …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Is the Expected CAGR for the Immunofluorescence Assay Market Through 2025?
In recent times, we've witnessed the substantial growth of the immunofluorescence assay market. The market, worth $3.34 billion in 2024, is projected to reach a value of $3.59 billion in 2025, which equates to a compound annual growth rate (CAGR) of 7.4%.…
Key Trends Shaping the Future Immunofluorescence Assay Market From 2025-2034: Te …
What market dynamics are playing a key role in accelerating the growth of the immunofluorescence assay market?
Rising cases of chronic illnesses are substantially propelling the growth of the immunofluorescence assay market. Shifting lifestyle patterns, food routines, and poor weight control are promoting the swift proliferation of chronic conditions, with specific prolonged chronic infections posing a threat of evolving into cancer. These escalating incidences of chronic disorders are anticipated to fuel…
Immunofluorescence Assay Market Report 2024 - Immunofluorescence Assay Market Si …
"The Business Research Company recently released a comprehensive report on the Global Immunofluorescence Assay Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Immunofluorescence Market Current Business Trend & Growth Opportunity
Market Analysis and Insights of Immunofluorescence Market
Immunofluorescence Market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 5.4% in the above-mentioned forecast period.
Immunofluorescence is defined as the technique used to visualize structures such as intermediate-sized filaments, and utilizes light microscopy in combination with fluorescence microscope on various microbiological samples. The various microbiological…
Immunofluorescence Analyzer Market: Views Sought On New Approach
The Global Immunofluorescence Analyzer Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2020-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Immunofluorescence Analyzer Market report presents the detail analysis of the parent market based on elite players,…
Global Immunofluorescence Assay Market – Forecast to 2026
Based on the GME predictions, the Global Immunofluorescence Assay Market would grow with a CAGR value of 6.25%and cross USD 3.50 billion by 2026. Immunofluorescence Assay (IFA) is also known as a usual virologic technique used to identify the existence of antibodies in infected cells.The demand for Immunofluorescence Assay is indirectly related to the rate of diseases
Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth…
